Does Clarithromycin Interact with Ranitidine Bismuth Citrate?
CDI records a minor classification for Clarithromycin and Ranitidine Bismuth Citrate. The stored summary is: Clarithromycin increases plasma ranitidine concentrations (57%), bismuth trough concentrations (48%), and 14-hydroxy-clarithromycin (31%). These effects are clinically insignificant. The mechanism involves clarithromycin inhibits ranitidine and bismuth metabolism. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Minor
- Clarithromycin Class
- Macrolide Antimicrobial
- Management
- Generally manageable
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Clarithromycin inhibits ranitidine and bismuth metabolism
What To Tell Your Doctor or Pharmacist
If you are taking Clarithromycin and your doctor is considering prescribing Ranitidine Bismuth Citrate (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Never stop or change either medication without first consulting your healthcare provider